Junli Li

National Medical Products Administration

Also affiliated with Sichuan University, West China Hospital of Sichuan University, Zoucheng People's Hospital, National Institutes for Food and Drug Control, National Health Council

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice”.

The Effects of ATIR Blocker on the Severity of COVID-19 in Hypertensive Inpatients and Virulence of SARS-CoV-2 in Hypertensive hACE2 Transgenic Mice

Journal of Cardiovascular Translational Research(2022)10.1007/s12265-021-10147-3

N/A

0.269DataRank · unranked

5 citations

Huadong Li, Yong Liu, Linlin Bao, Lingjun Zhan, Hong Gao +15 more

Application of High-Z Gold Nanoparticles in Targeted Cancer Radiotherapy—Pharmacokinetic Modeling, Monte Carlo Simulation and Radiobiological Effect Modeling

Cancers(2021)10.3390/cancers13215370

N/A

0DataRank · unranked

22 citations

Stefan Stangl, A.P. Klapproth, Maxim Shevtsov, Alicia Hernández, Melanie A. Kimm +9 more